May 31, 2021
EA Pharma and Kissei Pharmaceutical said on May 28 that a new drug application has been submitted in Japan for AJM300 (carotegrast methyl), an investigational ulcerative colitis (UC) treatment being jointly developed by the two companies. The submission is supported...read more